WASHINGTON (Reuters) - Roche Holding AG’s fat blocker Xenical helped people with high blood pressure to lower it, while Abbott Laboratories’ appetite suppressant Meridia did not, European researchers reported on Monday.
WASHINGTON (Reuters) - Roche Holding AG’s fat blocker Xenical helped people with high blood pressure to lower it, while Abbott Laboratories’ appetite suppressant Meridia did not, European researchers reported on Monday.
